Achieve Life
ACHV
7.24
+0.21
+2.99%
Achieve Life
US · ACHV
#3471 by market cap
7.24
+0.21
+2.99%
Live - 5344 symbols - heartbeat 469s ago
· 2026-10-08 09:06
Pre-market
7.19
-0.69%
After-hours
7.32
+1.10%
Overnight
7.27
+0.41%
- Market cap
- 746.46M
- P/E (TTM)i
- -4.36
- P/Bi
- -50.99
- EPSi
- -1.25
- Div yieldi
- 0.00%
- 52W posi
- 77%
Reader sentiment
Are you bullish or bearish on ACHV?
Anonymous reader poll. Unscientific, not investment advice.
About Achieve Life
Achieve Life Sciences, Inc. is a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence. Its products include cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Bothell, WA.
- Founded
- 1991
- CEO
- Dr. Andrew Goldberg, M.D.
- Employees
- 28
- Headquarters
- Bothell, Washington, United States of America
- Fiscal year end
- 12-31
- Website
- achievelifesciences.com
Company profile
- Exchange
- US
- Symbol
- ACHV
- Market-cap rank
- #3471
- Market cap
- 746.46M
- Float cap
- 542.21M
- Shares out
- 103.10M
- Float shares
- 74.89M
Sectors & themes
Biotechnology
Quote time 2026-10-08 09:06:46 · For reference only, not investment advice and not tailored to your situation.